​
​

LENZ Therapeutics (GRPH) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

LENZ Therapeutics Revenue Highlights

00

LENZ Therapeutics Revenue by Period

LENZ Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

LENZ Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

LENZ Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$10.24M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

LENZ Therapeutics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

LENZ Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$33.43M
ASMBAssembly Biosciences$7.16M$6.84M
NXTCNextCure--
TILInstil Bio--
GRPHLENZ Therapeutics--
NLTXNeurogene--
ACHLAchilles Therapeutics--
SNSESensei Biotherapeutics--
MACKMerrimack Pharmaceuticals--
NUVBNuvation Bio-$727.00K

GRPH Revenue FAQ

What is LENZ Therapeutics’s yearly revenue?

LENZ Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. GRPH's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is LENZ Therapeutics’s quarterly revenue?

LENZ Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $10.24M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). GRPH's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is LENZ Therapeutics’s revenue growth rate?

LENZ Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.